# Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)

> **NCT01416961** · PHASE1 · WITHDRAWN · sponsor: **Barbara Ann Karmanos Cancer Institute**

## Conditions studied

- Lung Cancer

## Interventions

- **RADIATION:** Radiation Therapy
- **DRUG:** Chemotherapy - Squamous Cell Histologies
- **DRUG:** Chemotherapy - NSCLC other than squamous cell

## Key facts

- **NCT ID:** NCT01416961
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-08
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Neutron therapy has become unavailable
- **Last updated:** 2012-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416961, "Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01416961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*